KPIs & Operating Metrics(New)
Growth Metrics

Aurora Cannabis (ACB) Accounts Payables (2017 - 2025)

Aurora Cannabis has reported Accounts Payables over the past 9 years, most recently at $48.8 million for Q4 2025.

  • Quarterly Accounts Payables fell 2.59% to $48.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.8 million through Dec 2025, down 2.59% year-over-year, with the annual reading at $51.3 million for FY2025, 18.03% up from the prior year.
  • Accounts Payables was $48.8 million for Q4 2025 at Aurora Cannabis, up from $35.9 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $74.1 million in Q3 2022 and troughed at $28.6 million in Q3 2024.
  • The 5-year median for Accounts Payables is $46.1 million (2023), against an average of $46.9 million.
  • Year-over-year, Accounts Payables plummeted 57.26% in 2021 and then skyrocketed 71.03% in 2022.
  • A 5-year view of Accounts Payables shows it stood at $41.9 million in 2021, then skyrocketed by 34.08% to $56.2 million in 2022, then dropped by 18.49% to $45.8 million in 2023, then increased by 9.39% to $50.1 million in 2024, then dropped by 2.59% to $48.8 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Accounts Payables are $48.8 million (Q4 2025), $35.9 million (Q3 2025), and $58.7 million (Q2 2025).